REMS FDA Documents (Aveed)

Search results for:

testosterone IM

testosterone IM
Drug Name Form Strength Non-Formulary Restricted TX Sub Notes
Depo-Testosterone SOLUTION, INTRAMUSCULAR cypionate 200 mg/mL      
Display Androgens Class : 680800
Medication comments:
testosterone injection is special-order only for ICS, hold for inpatients/SNF.
USP <800> Hazardous Drug Assessment of Risk (AOR)
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances.
The following outlines must be followed.
generic (Brand) Route
[Packaging: Manufacturer ⇒ Dispense]		 Activities
testosterone (Depo-T) IM
[n/a]		   Stock @ IDBH? N
NIOSH Table 2B↑
Pharmacy:
Receiving / Storage / Preparation

Exposure Risk: minimal
 • Handling/preparation PPE Requirements: n/a
• Receiving from Distributor: Standard
• Pharmacy Storage Area: CSM
• Packaging/Reconstitution Location: n/a
• Compounding (Non-Sterile/Sterile) Location: n/a
• Omnicell Load: No
Transport • Transport (dose is placed inside a plastic sealable bag): Standard
Nursing:
Storage / Administration

Exposure Risk: low
 • Handling/administration PPE Requirements: Single pair of CX approved gloves. Wash hands after handling
• Storage of Finished dose in Nursing Area/Procedural Area: Picked up from Pharmacy
• Signage on Patient Door Required: No
• Manipulation of Dosage Form: n/a
• Special Manipulation for Administration: n/a
Disposal / Spills • Disposal of Drug Waste: Full-  Rx Destroyer 
Packaging- trash
• Disposol of Used PPE: trash bin (inside plastic bag)
• Spill management: Wear CX gloves;
items used to clean up spill should be placed in a sealed bag and put in purple bin
NIOSH Supplemental Information: Children should avoid contact with unwashed or unclothed application sites on skin
2023 American Geriatrics Society Beers Criteria® for potentially inappropriate medication use in older adults.
Medication: testosterone (Androderm, AndroGel, Aveed, Depo-testosterone, Fortesta, Testim, Vogelxo)
Criteria 1: Potentially inappropriate medication use in older adults. (Table 2)
Drug(s) androgens
Rationale Potential for cardiac problems; potential risks in men with prostate cancer.
Recommendation Avoid unless indicated for confirmed hypogonadism with clinical symptoms.
 Quality of evidence: Moderate, Strength of Recommendation: Weak
Last updated: Sep. 19, 2025
  • Hazard.Drug Handling(USP 800) USP<800> Hazardous Drug / Assessment of Risk
UpToDate Lexidrug

Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556



This site is intended for the staff of Iredell Health System. While others may view accessible pages, Iredell Health System makes no warranty, express or implied, as to the use of this information outside of Iredell Health System. The content of this policy and procedure document serves as guidance to the delivery of quality patient care. Care providers are expected to exercise critical thinking and situational awareness skills, and in specific situations to take such action as is necessary for the delivery of quality patient care.
Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved